The GE HealthCare-Mayo MI-BET collaboration advances biomarker-guided prostate cancer therapy. The precision oncology market, valued at $122.6B in 2025, is projected to reach $317.2B by 2034, fueled by genomics and targeted treatments.
Recent market reports forecast significant growth in the progressive pulmonary fibrosis market, set to reach $2.7 billion by 2035, and the global asthma and COPD drugs market, projected to hit US$ 82.2 billion by 2036. The Asia Pacific pharma 4.0 market is also expanding rapidly, driven by digital technologies like AI and IoT.
GE HealthCare expanded a BARDA deal by $35M for AI ultrasound; Wavelet Medical partnered with Aegis Ventures to advance AI fetal EEG. Both aim to improve diagnostic speed and accuracy.
The global radiopharmaceuticals market is projected to reach $12.8B–$21.8B by 2033–2036, driven by cancer therapy demand. Oncology accounts for over 50% of applications, Technetium-99m dominates radioisotopes, and Asia-Pacific leads growth.
GE HealthCare announced FDA 510(k) clearances for its View diagnostic viewer within the Genesis Radiology Workspace and three new Signa MRI systems, including helium-free technology and AI-powered workflow solutions.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07725237 |
SPECT/CT Prospective Double-Scanning Study |
NOT_YET_RECRUITING | |
| NCT07697950 |
NIBP Accuracy Study for Adult Subject Populations |
RECRUITING | NA |
| NCT07684885 |
NIBP Study for Neonate and Pediatric Subject Populations |
RECRUITING | NA |
| NCT07684859 |
NIBP Accuracy Study for Adult |
WITHDRAWN | |
| NCT07661706 |
Data Collection of New Spectral CT Imaging Method |
RECRUITING | |
| NCT07628296 |
Non-Invasive Blood Pressure Accuracy Study for Adult Subject Populations |
RECRUITING | NA |
| NCT07615738 |
SpO2 Infant and Pediatric Study |
NOT_YET_RECRUITING | NA |
| NCT07609225 |
Chemical-Shift-Encoded MRI for Active Bone Marrow Dosimetry in Radiopharmaceutical Therapy |
NOT_YET_RECRUITING | EARLY_PHASE1 |
| NCT07472491 |
A Phase 2/3 Study on the Efficacy and Safety of Mangaciclanol for Contrast-Enhanced MRI of CNS or Body in Adult Patients |
RECRUITING | PHASE2/PHASE3 |
| NCT07394140 |
NMT EasyFit Sensor and Cable |
RECRUITING | NA |
